missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human TRANCE/RANK L/TNFSF11 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
5360.00 NOK
Specifications
| Gene ID (Entrez) | 8600 |
|---|---|
| Molecular Weight (g/mol) | 23 kDa |
| Name | TRANCE/TNFSF11/RANK L |
| Quantity | 10 μg |
| Source | Mouse myeloma cell line,NS0-derived human TRANCE/TNFSF11/RANK L protein, (N-terminus) MHHHHHHHHHH GGGSGGGSGGGS IEGR Human TRANCE (Gly64-Asp245) Accession &Num; AAC51762 (C-terminus) |
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|
18117110
|
R&D Systems™
390-TN-010 |
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. |
5360.00 NOK
10µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18334987
|
R&D Systems™
390-TN-010/CF |
Lyophilized from a 0.2μm filtered solution in PBS. |
5360.00 NOK
10µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
The Recombinant Human TRANCE/RANK L/TNFSF11 Protein is derived from NS0. The Recombinant Human TRANCE/RANK L/TNFSF11 Protein has been validated for the following applications: Bioactivity.Specifications
| 8600 | |
| TRANCE/TNFSF11/RANK L | |
| Mouse myeloma cell line,NS0-derived human TRANCE/TNFSF11/RANK L protein, (N-terminus) MHHHHHHHHHH GGGSGGGSGGGS IEGR Human TRANCE (Gly64-Asp245) Accession &Num; AAC51762 (C-terminus) | |
| Unconjugated | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 23 kDa | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |